The global Recombinant Human Serum Albumin market was valued at US$ 64.85 million in 2020, will reach US$ 105.58 million by the end of 2027, growing at a CAGR of 7.25% during 2022-2027.
This report focuses on Recombinant Human Serum Albumin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Serum Albumin market size by analysing historical data and future prospect.
Regionally, this report categorizes the sales of Recombinant Human Serum Albumin in North America, Europe, China, India, etc.
For the manufacturers covered, this report analyses the Recombinant Human Serum Albumin manufacturing sites, sales, ex-factory price, revenue, and market share for each company.
By Company
- Albumedix
- Merck
- Ventria (InVitria)
- NCPC
- Oryzogen
- HiMedia
Segment by Type
Segment by Application
- Cell Culture Media
- Medical Supplements
- Other
By Region
- North America
- Europe
- Japan
- China
- India
- Japan
- Southeast Asia
TABLE OF CONTENTS
1 INDUSTRY OVERVIEW OF RECOMBINANT HUMAN SERUM ALBUMIN
- 1.1 Definition of Recombinant Human Serum Albumin
- 1.2 Recombinant Human Serum Albumin Segment by Type
- 1.2.1 Global Recombinant Human Serum Albumin Revenue Growth Rate Comparison by Type (2021-2027)
- 1.2.2 OsrHSA
- 1.2.3 ScrHSA
- 1.3 Recombinant Human Serum Albumin Segment by Application
- 1.3.1 Global Recombinant Human Serum Albumin Revenue Comparison by Application (2021-2027)
- 1.3.2 Cell Culture Media
- 1.3.3 Medical Supplements
- 1.4 Recombinant Human Serum Albumin Overall Market: 2016 VS 2021 VS 2027
- 1.4.1 Global Recombinant Human Serum Albumin Revenue (2016-2027)
- 1.4.2 Global Recombinant Human Serum Albumin Sales (2016-2027)
- 1.4.3 North America Recombinant Human Serum Albumin Status and Prospect (2016-2027)
- 1.4.4 Europe Recombinant Human Serum Albumin Status and Prospect (2016-2027)
- 1.4.5 Japan Recombinant Human Serum Albumin Estimates and Projections (2016-2027)
- 1.4.6 China Recombinant Human Serum Albumin Status and Prospect (2016-2027)
- 1.4.7 India Recombinant Human Serum Albumin Status and Prospect (2016-2027)
- 1.4.8 Southeast Asia Recombinant Human Serum Albumin Estimates and Projections (2016-2027)
2 MANUFACTURING COST STRUCTURE ANALYSIS
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Recombinant Human Serum Albumin
- 2.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin
- 2.4 Industry Chain Structure of Recombinant Human Serum Albumin
3 DEVELOPMENT AND MANUFACTURING PLANTS ANALYSIS OF RECOMBINANT HUMAN SERUM ALBUMIN
- 3.1 Top Manufacturers Headquarters, Rank by Recombinant Human Serum Albumin Sales
- 3.2 Global Recombinant Human Serum Albumin Manufacturing Plants Distribution and Founded Date
- 3.3 Major Manufacturers Recombinant Human Serum Albumin Product Offered
- 3.4 Recent Development and Expansion Plans
4 KEY FIGURES OF MAJOR MANUFACTURERS
- 4.1 Global Top Manufacturers Recombinant Human Serum Albumin Sales Analysis
- 4.2 Global Top Manufacturers Recombinant Human Serum Albumin Revenue Analysis
- 4.3 Global Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.4 Global Top Manufacturers Recombinant Human Serum Albumin Price Analysis
- 4.5 Market Concentration Degree
5 RECOMBINANT HUMAN SERUM ALBUMIN REGIONAL MARKET ANALYSIS
- 5.1 Recombinant Human Serum Albumin Sales by Regions (2016-2021)
- 5.1.1 Global Recombinant Human Serum Albumin Sales by Regions (2016-2021)
- 5.1.2 Global Recombinant Human Serum Albumin Revenue by Regions
- 5.2 Recombinant Human Serum Albumin Sales by Regions (2022-2027)
- 5.2.1 Global Recombinant Human Serum Albumin Sales by Regions (2022-2027)
- 5.2.2 Global Recombinant Human Serum Albumin Revenue by Regions
- 5.3 North America Recombinant Human Serum Albumin Market Analysis
- 5.3.1 North America Recombinant Human Serum Albumin Sales
- 5.3.2 Key Players in North America
- 5.4 Europe Recombinant Human Serum Albumin Market Analysis
- 5.4.1 Europe Recombinant Human Serum Albumin Sales
- 5.4.2 Key Players in Europe
- 5.5 Japan Recombinant Human Serum Albumin Market Analysis
- 5.5.1 Japan Recombinant Human Serum Albumin Sales
- 5.5.2 Key Players in Japan
- 5.6 China Recombinant Human Serum Albumin Market Analysis
- 5.6.1 China Recombinant Human Serum Albumin Sales
- 5.6.2 Key Players in China
- 5.7 Southeast Asia Recombinant Human Serum Albumin Market Analysis
- 5.7.1 Southeast Asia Recombinant Human Serum Albumin Sales
- 5.7.2 Key Players in Southeast Asia
- 5.8 India Recombinant Human Serum Albumin Market Analysis
- 5.8.1 India Recombinant Human Serum Albumin Sales
- 5.8.2 Key Players in India
6 RECOMBINANT HUMAN SERUM ALBUMIN SEGMENT MARKET ANALYSIS (BY TYPE)
- 6.1 Global Recombinant Human Serum Albumin Market Size by Type (2016-2021)
- 6.1.1 Global Recombinant Human Serum Albumin Sales by Type (2016-2021)
- 6.1.2 Global Recombinant Human Serum Albumin Revenue by Type (2016-2021)
- 6.2 Global Recombinant Human Serum Albumin Market Size by Type (2022-2027)
- 6.2.1 Global Recombinant Human Serum Albumin Sales by Type (2022-2027)
- 6.2.2 Global Recombinant Human Serum Albumin Revenue by Type (2022-2027)
- 6.3 Recombinant Human Serum Albumin Price by Type
7 RECOMBINANT HUMAN SERUM ALBUMIN SEGMENT MARKET ANALYSIS (BY APPLICATION)
- 7.1 Overview
- 7.2 Global Recombinant Human Serum Albumin Sales Market Share by Application (2016-2021)
- 7.3 Global Recombinant Human Serum Albumin Sales Market Share by Application (2022-2027)
- 7.4 Global Recombinant Human Serum Albumin Revenue Market Share by Application (2016-2021)
- 7.5 Global Recombinant Human Serum Albumin Revenue Market Share by Application (2022-2027)
8 COMPANY PROFILES AND KEY FIGURES IN RECOMBINANT HUMAN SERUM ALBUMIN BUSINESS
- 8.1 Albumedix
- 8.1.1 Albumedix Corporation Information
- 8.1.2 Albumedix Recombinant Human Serum Albumin Products Offered
- 8.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2021)
- 8.1.4 Albumedix Recent Developments
- 8.2 Merck
- 8.2.1 Merck Corporation Information
- 8.2.2 Merck Recombinant Human Serum Albumin Products Offered
- 8.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2021)
- 8.2.4 Merck Recent Developments
- 8.3 Ventria (InVitria)
- 8.3.1 Ventria (InVitria) Corporation Information
- 8.3.2 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered
- 8.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2021)
- 8.3.4 Ventria (InVitria) Recent Developments
- 8.4 NCPC
- 8.4.1 NCPC Corporation Information
- 8.4.2 NCPC Recombinant Human Serum Albumin Products Offered
- 8.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2021)
- 8.5 Oryzogen
- 8.5.1 Oryzogen Corporation Information
- 8.5.2 Oryzogen Recombinant Human Serum Albumin Products Offered
- 8.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2021)
- 8.6 HiMedia
- 8.6.1 HiMedia Corporation Information
- 8.6.2 HiMedia Recombinant Human Serum Albumin Products Offered
- 8.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2021)
9 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
- 9.1 Marketing Channel
- 9.1.1 Direct Channels
- 9.1.2 Indirect Channels
- 9.2 Recombinant Human Serum Albumin Distributors List
- 9.3 Recombinant Human Serum Albumin Customers
- 9.3.1 Thermo Fisher
- 9.3.2 STEMCELL Technologies
- 9.3.3 Merck Millipore
- 9.3.4 Lonza
- 9.3.5 Miltenyi Biotec
- 9.3.6 GSK
- 9.3.7 Merck
- 9.3.8 Sanofi
- 9.3.9 Changchun Institute of Biological
10 RECOMBINANT HUMAN SERUM ALBUMIN MARKET DYNAMICS
- 10.1 Recombinant Human Serum Albumin Industry Trends
- 10.2 Recombinant Human Serum Albumin Market Drivers
- 10.3 Recombinant Human Serum Albumin Market Challenges
- 10.4 Recombinant Human Serum Albumin Market Restraints
- 10.5 Porter's Five Forces Analysis
11 CONCLUSION
12 APPENDIX
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
- 12.4 Disclaimer 96